Eaton AF, Yue Q, Eaton DC, Bao HF. ENaC activity and expression is decreased in the lungs of protein kinase C-␣ knockout mice. Am J Physiol Lung Cell Mol Physiol 307: L374 -L385, 2014. First published July 11, 2014 doi:10.1152/ajplung.00040.2014.-We used a PKC-␣ knockout model to investigate the regulation of alveolar epithelial Na ϩ channels (ENaC) by PKC. Primary alveolar type II (ATII) cells were subjected to cell-attached patch clamp. In the absence of PKC-␣, the open probability (Po) of ENaC was decreased by half compared with wild-type mice. The channel density (N) was also reduced in the knockout mice. Using in vivo biotinylation, membrane localization of all three ENaC subunits (␣, ␤, and ␥) was decreased in the PKC-␣ knockout lung, compared with the wild-type. Confocal microscopy of lung slices showed elevated levels of reactive oxygen species (ROS) in the lungs of the PKC-␣ knockout mice vs. the wild-type. High levels of ROS in the knockout lung can be explained by a decrease in both cytosolic and mitochondrial superoxide dismutase activity. Elevated levels of ROS in the knockout lung activates PKC-␦ and leads to reduced dephosphorylation of ERK1/2 by MAP kinase phosphatase, which in turn causes increased internalization of ENaC via ubiquitination by the ubiquitin-ligase Nedd4 -2. In addition, in the knockout lung, PKC-␦ activates ERK, causing a decrease in ENaC density at the apical alveolar membrane. PKC-␦ also phosphorylates MARCKS, leading to a decrease in ENaC Po. The effects of ROS and PKC-␦ were confirmed with patch-clamp experiments on isolated ATII cells in which the ROS scavenger, Tempol, or a PKC-␦-specific inhibitor added to patches reversed the observed decrease in ENaC apical channel density and Po. These results explain the decrease in ENaC activity in PKC-␣ knockout lung.
A THIN LAYER OF FLUID ON THE APICAL SURFACE of the alveolar epithelium is critical for efficient gas exchange in the lung. This fluid layer is maintained by a balance between passive fluid secretion into the airway lumen, driven by hydrostatic pressure and active reabsorption of fluid into the vascular space (11) .
Active sodium (Na ϩ ) transport from the airspace, across the alveolar epithelium, and into the pulmonary interstitium is the major mechanism for regulating lung fluid balance. Epithelial Na ϩ channels (ENaC) are responsible for the majority of Na ϩ transport across the apical membranes of alveolar epithelial cells (11, 20) . The Na ϩ that enters the cells is subsequently transported by the Na ϩ /K ϩ -ATPase out of the cell and into the interstitium and pulmonary capillaries. This active Na ϩ transport, via ENaC, creates an osmotic potential across the apical alveolar epithelium. This osmotic gradient is the driving force in the removal of water from the distal air spaces in the lung or alveolar fluid clearance (AFC). The application of amiloride, an ENaC-specific inhibitor, reverses the majority of AFC, indicating that ENaC is indeed central to maintenance of proper fluid balance in the lung (20) .
ENaC can be regulated either by altering the time individual channels remain open (open probability, or P o ), or by modifying expression of functional sodium channels in the membrane (N). An important signaling molecule that regulates ENaC is protein kinase C (PKC). Activation of PKC has been shown to reduce ENaC activity in A6 cells, a renal cell line (32, 48) , and principal cells from rat kidney (15) ; conversely, inhibition of PKC has been observed to increase ENaC P o (32, 53) . Our laboratory has recently shown that ENaC activity and expression are significantly increased in isolated split-open collecting duct tubules from PKC-␣ knockout mice (3) . One prior report and our current work have shown that there is only one PKC isoform, ␣, present in principal cells (30, 43) , whereas there are multiple PKC isoforms in the lung (49) . This suggested that the mechanism for PKC regulation of ENaC in the lung could be quite different than in the kidney. Therefore, we made use of the same PKC-␣ knockout mouse model to examine the regulation of ENaC by PKC in alveolar epithelium.
MATERIALS AND METHODS

Animals.
The original PKC-␣ knockout mice were acquired from the laboratory of Dr. Jeffery Molkentin at the University of Cincinnati (34) , and a colony was established at Emory University. Control mice were bred by backcrossing PKC-␣ knockout mice with SV129 control animals for ten generations. Subsequently, the wild-type line was maintained as a control for the PKC-␣ knockout mice. Mice were kept on a 12-h:12-h light/dark cycle and fed standard laboratory chow with tap water ad libitum. All animal protocols were approved by the Emory Institutional Care and Use Committee.
Antibody production. Polyclonal antibodies for the extracellular domain of the ␣-subunit of ENaC (890) and the carboxyl terminal domains of the ␤-subunit (60) and ␥-subunit (2,102) of ENaC were generated in White New Zealand rabbits by Bio-Synthesis, Lewisville, TX using constructs made in house as described by Bao et al. (3) .
Evan's blue protein assay. A solution comprised of 5% bovine serum albumin and 0.1 mg/ml Evan's blue dye was tracheally instilled, as described previously (26) , in PKC-␣ knockout mice and SV129 control mice. The Evan's blue solution was extracted from the lung after 30 min. AFC was calculated using the formula: AFC ϭ [(V i Ϫ Vf)/Vi] ϫ 100; where Vi is the initial volume of instillate, and V f is the final alveolar fluid volume. Vf ϭ (Vi ϫ EB i)/EBf, where EBi is the concentration of Evan's blue-labeled albumin in the instilled solution, and EB f is the final concentration of Evan's blue in the alveolar fluid (19) . Protein concentration was determined using the Nanodrop 2000 spectrophotometer (Thermo Scientific, Wilmington, DE).
Wet:dry weight assay. Whole lungs from PKC-␣ knockout and SV129 animals were bled out, extracted, and weighed immediately following removal (wet weight). Subsequently, the lungs were desiccated overnight, at 110°C, and reweighed (dry weight). The wet-todry ratio was determined by dividing the wet weight by the dry weight, which represents the amount of airway fluid and is a measure of the rate of AFC. A larger ratio indicates more fluid in the lungs initially (less AFC), which implies less sodium transport attributable to decreased ENaC activity, whereas a smaller ratio indicates dryer lungs (more AFC) because of increased sodium transport via ENaC.
Chemicals. Most chemicals were obtained from Sigma-Aldrich (St. Louis, MO) except for the pseudo-substrate PKC-␦ inhibitor, ␦-PKC (8 -17) , from AnaSpec (Fremont, CA), and the mitogen kinase phos-
. This inhibitor is a cell-permeable cyclohexylamino-indenone compound that acts as an allosteric inhibitor against substrate bindinginduced MAPK phosphatase activity of Dusp1/MKP1 and Dusp6/ MKP3 by locking Dusp1 and Dusp6 in their low-activity conformation. The inhibitor effectively enhances cellular ERK phosphorylation in cells overexpressing human Dusp1 and Dusp6 (EC 50 ϭ 11.5 and 12.3 M, respectively) (39) .
Fluorescent labeling and detection of reactive oxygen species. Lung slices (125 m) were prepared, as described previously (24), from wild-type and PKC-␣ knockout mice. Subsequently, the slices were covered and incubated in 10 M dihydroethidium (DHE) with 10 M Erythrina crista-galli lectin (ECL), an alveolar type I cell marker, for 30 min at 37°C. It has been reported that production of 2-hydroxyethidium from DHE is an accurate reporter of superoxide production (12, 19, 24, 24, 51) . After incubation, DHE fluorescence was analyzed using confocal microscopy at excitation/emission 520/ 610 nm (19) , and data were quantified using Image J (an open-source image analysis program).
Determining superoxide dismutase activity. Superoxide dismutase (SOD) activity in both wild-type and PKC-␣ knockout lung was determined using the Superoxide Dismutase Assay Kit (Cayman Chemical, Ann Arbor, MI). Samples were analyzed using a plate reader at excitation/emission 440/460 nm.
SDS-PAGE and immunoblotting. Freshly isolated lungs, from PKC-␣ knockout and SV129 control animals, were minced and then washed once with 1ϫ PBS and subsequently homogenized in tissue protein extraction reagent (Thermo Scientific) using an Omni TH homogenizer (Warrenton, VA). Tissue lysates were then centrifuged at 1,000 revolution/min, at 4°C, for 5 min. The supernatant was then sonicated twice, on ice, for 10 s. Lysate protein concentration was determined using the BCA protein assay (Thermo Scientific). Twentyfive micrograms of total protein were prepared in Laemmli sample buffer (Bio-Rad, Hercules, CA) and then loaded and resolved on 7.5% Tris·HCl polyacrylamide gels using the Criterion or Protean electrophoresis systems (Bio-Rad). The separated proteins were electrically transferred onto Immobilon-P transfer membranes (Millipore). The membranes were blocked in 5% wt/vol milk in 1ϫ TBS with Tween (TBST, Bio-Rad), at room temperature for 1 h. The membranes were washed once with 1ϫ TBST, and then incubated with primary antibody at a dilution of 1:1,000 in 5% wt/vol milk in 1ϫ TBST overnight at 4°C. The membranes were washed three times with 1ϫ TBST for 5-min intervals before being incubated with horseradish peroxidase-conjugated goat-anti-rabbit secondary antibody at a dilution of 1:5,000 in 5% wt/vol milk in 1ϫ TBST. The membranes were incubated with SuperSignal Dura Chemiluminescent Substrate for 5 min before being developed using a Kodak Gel Logic 2200 Imager and Carestream Molecular Imaging software (Carestream Health, Rochester, NY). This method was used to detect ENaC subunits (with in house antibodies) (1, 48, 52) , ERK1/2 (9102; Cell Signaling, Beverly, MA), phosphoERK1/2 (9101a, Cell Signaling), MARCKS (SC-6454; Santa Cruz Biotechnology, Santa Cruz, CA), and phospho-MARCKS (PA1-4629, Thermo Scientific). PKC-␣ was detected with an antibody from Cell Signaling (9375), and PKC-␦ was detected using an antibody from Genetex (GTX61153; San Antonio, TX).
In situ biotinylation. A protocol developed by Frindt and Palmer for in situ biotinylation of rat kidney (13, 14) was modified for use in mouse lung. Mice were anesthetized by intraperitoneal injection of 50 mg/kg sodium pentobarbital diluted in sterile saline. The abdominal and chest cavity were opened, and the aorta was cut to allow for bleeding out. An incision was made in the left atrium to release pressure, and the lung was perfused with PBS until the lungs appeared white or blanched. PBS containing 0.5 mg/ml sulfosuccinimidyl-2-[biotinamido]-ethyl-1,3-dithiopropionate (sulfo NHS biotin; Pierce, Rockford, IL) was allowed to flow through the lung via the trachea, after which the reaction was quenched by instilling the lung for 25 min with PBS containing 25 mM Tris·HCl, replacing the 25 mM NaCl. Subsequently, whole biotinylated lungs, from both wild-type and PKC-␣ knockout mice, were extracted, homogenized, and lysed in a buffer containing 250 mM sucrose and 10 mM triethanolamine (pH 7.4). To separate the total membrane fraction, the supernatant was centrifuged at 4°C for 6 h at 18,000 g. The total membrane fraction was suspended in 150 l lysis buffer, equally loaded onto streptavidin beads (high-capacity neutravidin agarose resin, Thermo Scientific), and incubated overnight. The unbound protein was removed from the beads by first washing three times with wash buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris, and 1% Triton-X 100, pH 7.4), followed by a high-salt wash (wash buffer with 500 mM NaCl), then two no-salt washes (10 mM Tris, pH 7.4). Afterward, the bound protein was eluted in sample buffer with 0.5 M dithiothreitol. Biotinylated and unbiotinylated fractions, from both the wild-type and PKC-␣ knockout animals, were run on 7.5% Tris·HCl polyacrylamide gels, and probed using in-house antibodies for ␣, ␤, and ␥ ENaC (as described above).
Single-channel patch clamp. Primary alveolar epithelial type II (ATII) cells were isolated from PKC-␣ knockout and SV129 control mice, as previously described (7, 8) . ATII cells were prepared on a permeable support before single-channel patch clamp, as previously described for patch clamp of cells in culture (23, 28) . Briefly, a microelectrode was filled with physiological buffer and applied to a single cell using suction, until a Ͼ1 G⍀ seal was formed. ENaC channels were identified by characteristic channel kinetics and the current-voltage relationship for the channel.
Data analysis and statistics. Data acquisition and analysis were performed as described previously (23) . Data are reported as means Ϯ SE. Statistical analysis was performed with SigmaPlot and SigmaStat software (Jandel Scientific, San Rafael, CA). Statistical significance was evaluated using t-test, z-test, or one-way ANOVA, as appropriate, and results were considered significant if P Ͻ 0.05.
RESULTS
Apical alveolar ENaC expression is decreased in protein kinase C-␣ knockout mice. We used PKC-␣ global knockout mice to investigate the effect of PKC-␣ on ENaC activity in the alveoli. In Western blots, PKC-␣ could be detected in whole lung lysates from wild-type mice but could not be detected in lung lysates from PKC-␣ knockout mice (Fig. 1A) . Western blotting showed no discernible difference in whole lung ENaC expression between the wild-type and knockout mice (Fig. 1B) . However, only ENaC at the surface of alveolar epithelial cells contributes to AFC, and ENaC can move from the membrane to an intracellular pool. Therefore, we used an in situ biotinylation technique (described in MATERIALS AND METHODS) to label proteins on the apical surface of the alveoli. After precipitating the biotin-labeled proteins from whole lung lysates, we resolved the precipitates on gels and probed for all three ENaC subunits (Fig. 1C) . The quantity of all three subunits (␣, ␤, and ␥) at the apical membrane in the knockout mice was decreased compared with wild-type (Fig. 1D) , showing that apical-membrane expression of ENaC is decreased in PKC-␣ knockout mice.
Sodium transport is decreased in the PKC-␣ knockout lung. We quantified physiological AFC using the wet:dry weight assay and the Evan's blue assay (Fig. 2) . For the wet:dry weight assay, a higher value indicates more fluid in the lung initially and that there is a lower level of AFC occurring, meaning there is decreased total sodium transport. We found that the knockout value was increased over the wild-type for the wet:dry weight assay ( Fig. 2A) . For the Evan's blue assay, a lower value indicates less absorption of fluid from the airspace (reduced AFC), also meaning there is reduced sodium transport in the lung. The value for knockout was significantly reduced compared with the wild-type for the Evan's blue assay as well (Fig. 2B ). Both of these values indicate that overall sodium transport is reduced in the PKC-␣ knockout lung compared with wild-type.
Alveolar ENaC activity is decreased in PKC-␣ knockout mice. ENaC activity was recorded using cell-attached patch clamp on isolated ATII cells from PKC-␣ knockout mice and wild-type mice (Fig. 3A) . The longer traces are representative single-channel records from wild-type or knockout ATII cells. ENaC activity is significantly decreased in the PKC-␣ knockout lungs vs. in the wild-type. The expanded regions of the traces show inward current with long mean open and close times, which are characteristic of ENaC (Fig. 3A) . Figure 3B shows the current-voltage relationship for the channel in Fig.  3A . The inward rectification and highly positive reversal potential also distinguish ENaC. Figure 3C Western blots of total lung homogenates from wild-type (WT) and PKC-␣ knockout mice, demonstrating that there is no PKC-␣ present in the knockout lung. The expected molecular weight is 80 -82 kDa. 25 g of lysate were loaded per well. B: Western blots of total lung homogenate from wild-type and PKC-␣ knockout mice illustrating that there is no significant difference in total amount of ENaC present in the 2 groups. C: biotinylated ENaC subunits. Whole lungs were homogenized, and protein was extracted. The membrane fraction was equally loaded onto streptavidin beads and incubated overnight. After being washed, protein was eluted with sample buffer, resolved on gels, and detected with ENaC-specific antibodies. The amount of each of the biotinylated subunits was less in the PKC-␣ knockout lungs than in the wild-type. D: ratio of the band densities in lungs from knockout animals vs. wild-type. Each ratio is Ͻ1, indicating that ENaC subunits are reduced in knockout animals (␣, *P ϭ 0.031; ␤, *P ϭ 0.046; ␥, *P ϭ 0.039 by 1 sample t-test; average of 3 experiments for each type of animal). Sodium transport is decreased in the PKC-␣ knockout lung. We quantified physiological alveolar fluid clearance (AFC) using the wet/dry weight assay and the Evan's blue assay. We found that the knockout value was increased over the wild-type for the wet:dry weight assay (A). The value for knockout was significantly reduced compared with the wild-type for the Evan's blue assay as well (B). *Both of these values indicate that overall sodium transport is reduced in the PKC-␣ knockout lung compared with wild-type.
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isolated from both wild-type and knockout animals. Wild-type data are from 29 individual patches; knockout data are from 32 individual patches. ATII cells were isolated from six wild-type mice and nine PKC-␣ knockout mice. ENaC activity is quantified as NP o , which is the product of the number of channels per patch (N) and the P o . Using this measure, ENaC activity was decreased more than threefold in the knockout animals, compared with the wild-type (Fig. 3C ). The decrease in ENaC activity (NP o ) in the PKC-␣ knockout mice is due to a decrease in both P o ( Fig. 3D) and N ( Fig. 3E) . In a separate series of experiments in which we examined 29 patches from knockout mice and 69 patches from wild-type, the number of successful patches that had no ENaC present was nearly six times greater in the knockout mice compared with the wild-type (Fig. 3F ), implying that there may be a significant reduction in apical channel density. This decrease in overall ENaC activity in the knockout animals was surprising in the face of previous findings that ENaC activity in the kidney is increased in PKC-␣ knockout mice (3); therefore, we decided to investigate further the decreased ENaC activity in the lung of PKC-␣ knockout mice.
Knocking out PKC-␣ increases superoxide production in the alveoli. One trait that distinguishes alveolar ENaC from ENaC in other tissues is exposure to relatively high levels of oxygen and the concomitant elevated reactive oxygen species (ROS). High concentrations of ROS in the lung play an integral part in the signaling cascade involved in regulating lung fluid balance via ENaC (11) . Using immunohistochemistry and confocal microscopy of lung slices, we examined superoxide production in the knockout mice compared with the wild-type mice. ATI cells are labeled green using green fluorescent protein-ECL, and superoxide is labeled with DHE, indicated by red color (as described in MATERIALS AND METHODS). Figure 4A , top, is divided into four images of the same slice. Figure 4A , top, left, shows the white light image merged with ECL and DHE; Fig.  4A , top, right, shows ECL and DHE merged; Fig. 4A , bottom, left shows DHE alone; Fig. 4A , bottom, right, shows DHE merged with the white light image. Figure 4A , bottom, displays an enlarged view of the DHE fluorescence. The PKC-␣ knockout mice show higher levels of superoxide (Fig. 4B) than the wild-type mice (Fig. 4A) . In data not shown, we used Image J to quantify the intensity of the DHE fluorescence over the entire field, and we observed a twofold increase in DHE intensity in the knockout animals, indicating that the superoxide levels are significantly elevated in the PKC-␣ knockout mice over the wild-type mice.
Knocking out PKC-␣ decreases SOD activity in the lung. PKC-␣ can decrease production of ROS via activation of SOD (27) . The absence of PKC-␣ activation of SOD could explain the elevated ROS levels observed in the PKC-␣ knockout animals (Fig. 4B) . indicates that SOD activity is indeed decreased significantly in the knockout animals. The kit allowed for separate determination of cytosolic and mitochondrial SOD activity. Both decreased significantly, but the decrease in the mitochondrial SOD in knockout lungs was larger (compare Fig. 4D with Fig.  4E ). Overall, there is a net decrease in total SOD activity in the PKC-␣ knockout mice, which explains the elevated levels of ROS in the knockout animals (Fig. 4, A and B) . ROS scavenging increases ENaC activity in the PKC-␣ knockout lung. ENaC activity was recorded from cell-attached patches on isolated ATII cells (as in Fig. 3A) , from wild-type mice or PKC-␣ knockout mice, before and after addition of Tempol, a superoxide scavenger. The addition of Tempol to isolated ATII cells from the PKC-␣ knockout mice resulted in an increase in ENaC activity in knockout mice (Figs. 3A and 7A ) compared with the wild-type (Figs.  3A and 7B) , as discussed below. These results along with SOD activity measurements and fluorescent superoxide quantification strongly implicate an increase in ROS as the causative agent behind the change in ENaC activity in the PKC-␣ knockout lung.
ERK1/2 activity is increased in the PKC-␣ knockout lung. The ubiquitin ligase, Nedd4 -2, controls ENaC channel density at the apical membrane (45, 46, 56) . ERK1/2 phosphorylation of ENaC augments the ability of Nedd4 -2 to ubiquitinate ENaC and promote internalization (4, 48) . Increased ERK 1/2 activity would explain the decreased channel density of ENaC at the apical membrane observed in the PKC-␣ knockout mice (Figs. 1C and 3, E and F) . We used ERK1/2 phosphorylation as a measure of ERK1/2 activity in the wild-type and knockout mice. We found that, although the total amount of ERK1/2 was comparable between the two groups, phosphorylated ERK1/2 was significantly increased in the knockout mice (Fig. 5) , which likely explains the decreased ENaC channel density at the alveolar surface. It has been previously reported that ROS activates ERK1/2 (42). The increase in ERK1/2 activity in the A: wild-type mice have lower levels of superoxide production than the knockout animals, as shown in B. DHE fluorescence was analyzed using confocal microscopy at excitation/emission 520/610 nm, and data were quantified using Image J. The intensity of the DHE fluorescence over the entire field was 2-fold greater in the knockout animals over the wild-type (P Ͻ 0.001 by t-test, n ϭ 3 separate animals for each type). C and D: superoxide dismutase (SOD) activity is decreased in the PKC-␣ knockout lung. We measured both cytosolic and mitochondrial SOD activity using Superoxide Dismutase Assay Kit (Cayman Chemical). Samples were analyzed using a plate reader at excitation/emission 440/460 nm. Asterisks indicate significant differences as determined by t-test (P Ͻ 0.05). C: shows a significant decrease in cytosolic SOD activity in the knockout mice compared with wild-type (P ϭ 0.034, 6 samples per mouse from 3 mice of each type). D: there is 2-fold decrease in mitochondrial SOD activity in the knockout lung vs. wild-type (P Ͻ 0.001; 6 samples per mouse from 3 mice of each type).
knockout animals parallels, and is presumably explained by, the increase in ROS we observed (Figs. 5 and 4B) .
MARCKS phosphorylation is increased in the PKC-␣ knockout lung. One well-established mechanism for the regulation of ENaC P o involves the interaction of phosphatidylinositol phosphate (PIP 2 ) with the channel (25, 35-37, 44, 54, 55) . More recently, it has been shown that a specialized scaffolding protein, MARCKS, associates with PIP 2 , allowing for a high level of interaction with ENaC at the membrane. The phosphorylation state of MARCKS corresponds to its capacity to sequester PIP 2 at the membrane in close proximity to ENaC; unphosphorylated MARCKS associates with the membrane and stabilizes PIP 2 near ENaC, increasing P o , whereas phosphorylated MARCKS disassociates from the membrane and enters the cytosol, which lowers PIP 2 concentrations in the vicinity of ENaC, causing ENaC P o to go down (1). We showed in Western blots that the levels of unphosphorylated MARCKS is comparable in the wild-type and knockout animals, but the levels of phosphorylated MARCKS is significantly increased in the PKC-␣ knockout mice, compared with the wild-type mice (Fig. 6 ). This increase in MARCKS phosphorylation explains the decrease in ENaC P o in the PKC-␣ knockout mice.
Channel density of ENaC increases with addition of Tempol. There was a significant increase in the channel density of ENaC at the membrane in the knockout mice after the addition of Tempol, but there was no significant change seen in the wild-type animals where ROS levels were already minimal (Fig. 7D) . There was also a significant increase in the P o of ENaC in the PKC-␣ knockout mice after the addition of Tempol, whereas there was no significant change in the wildtype mice (Fig. 7C) .
Inhibition of MKP in wild-type cells mimics the reduction in channel density in knockout animals. Phosphorylated ERK1/2 can phosphorylate ENaC and lead to ENaC internalization and degradation, thereby reducing the density of ENaC on the surface of ATII cells. The level of phosphorylation of ERK1/2 is determined by a balance between the rate at which ERK is phosphorylated by kinases, in particular PKC-␦, and the rate at which it is dephosphorylated by phosphatases, in particular MKP. Changes in activity of MKP can alter ENaC functional channel density (40) , and increases in cytosolic ROS inhibit MKP (5, 31) . Therefore, we investigated the effect of an MKP inhibitor on ENaC activity in wild-type and knockout cells. We predicted that inhibiting MKP in wild-type cells would increase ERK activity and make channel density in wild-type cells similar to that found in knockout cells. Also, because MKP should already be inhibited in knockout animals, there should be little effect of additional inhibition. Figure 8 shows that MKP inhibition does reduce channel density in wild-type cells but produces little effect on knockout cells. There appears to be little effect of MKP inhibitor on P o , which might be anticipated if the primary effect on P o is via MARCKS and not ERK.
Alternate PKC isoforms present in the lung. Whereas in renal principal cells there is only one detectable form of PKC, PKC-␣ (3), in alveoli there are multiple PKC isoforms (43); PKC-␣, -␤, -␦, -, and -can be detected in type II cells by immunoblotting (33) . One of these isoforms, PKC-␦, is gener- Fig. 5 . Active ERK1/2 is increased in the PKC-␣ knockout lung. Using Western blotting, we measured total ERK1/2 and phosphoERK1/2 in whole lung homogenates from PKC-␣ knockout and wild-type mice (A). We used Image J to quantify the blots using an area that included both ERK1 and ERK2 bands. The program calculated the average density of the bands above the background for individual bands. B: the mean densitometry values from 3 separate experiments illustrating that total ERK is the same (P ϭ 0.159), but phosphoERK is significantly increased in the knockout lung over the wild-type (*P ϭ 0.020; n ϭ 1 blot from 3 mice of each type). . Cytosolic MARCKS is increased in the PKC-␣ knockout lung. Using Western blotting, we measured total MARCKS and phosphoMARCKS in whole-lung homogenates from PKC-␣ knockout and wild-type mice (A). Unphosphorylated MARCKS protein is at the membrane, facilitating interactions that increase ENaC Po. When MARCKS is phosphorylated, it moves into the cytosol, causing a decrease in ENaC Po. We used Image J to quantify the blots. The program calculated the cumulative sum of the pixel values above the background for individual bands. Asterisks indicate significant differences as determined using a t-test (P Ͻ 0.05). B: mean densitometry values from 2 separate experiments, which show that total MARCKS is the same (P ϭ n.s.), but phosphoMARCKS is significantly increased in the knockout lung over the wild-type (*P ϭ 0.002; n ϭ 1 blot from 3 mice of each type).
ally inactive but is strongly activated by ROS (6) . Because our results show a role for ROS, we chose to investigate the levels of PKC-␦ in the PKC-␣ knockout vs. the wild-type lung. To become active, the inactive form of PKC-␦ must undergo modification, including tyrosine phosphorylation (29) and proteolytic cleavage. Using Western blotting, we observed that, although there is no change in total levels of PKC-␦ in the PKC-␣ knockout lung compared with the wild-type lung, there is a significant increase in the levels of active, phosphorylated, and cleaved PKC-␦ in the lungs of the PKC-␣ knockout mice (Fig. 9) .
Inhibition of PKC-␦ increases ENaC activity in the PKC-␣ knockout lung.
If activation of PKC-␦ is necessary for the decrease in ENaC activity in the knockout mice, then inhibiting PKC-␦ should, at least partially, restore the activity. ENaC activity was recorded from cell-attached patches on isolated ATII cells (as in Fig. 3A) , from wild-type mice or PKC-␣ knockout mice, before and after addition of the PKC-␦ inhibitor. The addition of the PKC-␦ inhibitor to isolated ATII cells from the PKC-␣ knockout mice resulted in an increase of the ENaC activity in the knockout cells (Fig. 10A ) that makes the activity comparable to that seen in wild-type (Fig. 10B) . The P o of ENaC in the PKC-␣ knockout mice showed a significant increase after the addition of the PKC-␦ inhibitor, whereas in the wild-type mice there was no significant change (Fig. 10C) . Concurrently, we observed a significant increase in the number of ENaC channels at the apical membrane in the knockout mice after the addition of the inhibitor, but there was no significant change in the wild-type animals (Fig. 10D) . This shows that the inhibition of PKC-␦ in the PKC-␣ knockout lung increases ENaC activity by increasing P o and by raising the density of channels at the apical membrane.
Generalized activation and inhibition of PKC. Given the information about the importance of both PKC-␣ and PKC-␦, we could predict the effects of activation and inhibition of all PKC isoforms in the lung. We would expect activation of PKC with phorbol myristoyl acetate to produce a profound inhibition of ENaC P o because both PKC-␣ and PKC-␦ would promote MARCKS phosphorylation and removal from the membrane, which would subsequently lead to the loss of PIP 2 activation of ENaC. General inhibition with an inhibitor that blocks most isoforms of PKC (GF109203X) should, in contrast, produce dramatic activation of ENaC because, after addition of the inhibitor, there will be no limitation on ENaC P o . Figure 11 shows that, in wild-type ATII cells, our predictions are true.
DISCUSSION
The effect of PKC on ENaC in renal epithelial cells and in distal nephron principal cells has been previously described in the literature (3, 15, 32, 48, 53) . With a few exceptions, previous reports have generally shown that PKC activity inhibits ENaC. Interestingly, despite the role of PKC as a protein kinase, ENaC does not appear to be directly phosphorylated by PKC (53) . Therefore, PKC must act indirectly to phosphorylate one or more ENaC regulatory proteins. The purpose of this work was to investigate which proteins might be modulated by PKC to alter ENaC activity in the lung.
PKC isoforms in the lung. Alveolar epithelial cells contain several different PKC isoforms. Transcripts encoding PKC-␣, -␤, -␦, -⑀, -, and -can be detected in type II cells by RT-PCR, and PKC-␣, -␤, -␦, -, and -can be detected in type II cells by immunoblotting (33) . PKC-␣ knockout animals presented us with an opportunity to determine the specific role of one of these PKC isoforms, ␣, on ENaC-mediated alveolar sodium transport. , whereas there was no significant change in the wild-type mice. D: significant increase in the channel density of ENaC at the membrane in the knockout mice after the addition of Tempol (*P ϭ 0.008), but there was no significant change seen in the wild-type animals (n ϭ 14).
AFC is reduced in the PKC-␣ knockout lung. We used two separate methods, the wet-dry ratio and Evans blue, to show that fluid clearance in the lungs in PKC-␣ knockout mice was reduced. This suggests that the normal mechanisms for fluid uptake must be compromised. We subsequently showed that sodium uptake via ENaC was reduced. However, previous work has shown that PKC-␣ downregulates both E-cadherin (50) and VE-cadherin (21), leading to an increase in barrier permeability following activation of PKC-␣. This suggests a possibility of increased alveolar and capillary barrier function in PKC-␣ knockout mice. We demonstrated that there was an increase in the activity of other PKC isoforms in the PKC-␣ knockout animals, specifically an increase in PKC-␦ activity. It has been reported that PKC-␦ may have a barrier-protective function attributable to increasing focal adhesion points (22) . The combination of the absence of a PKC-␣-stimulated increase in endothelial permeability and a decrease in endothelial permeability caused by increased PKC-␦ activation in the knockout animals suggests that the PKC-␣ knockout animals could have a less permeable endothelial barrier. This could also affect the observed alveolar fluid volume in the physiological measurements of AFC because the knockout animals with lower ENaC activity would have wetter lungs (which was observed), but, if there is decreased endothelial permeability, then the decreased permeability would partially compensate for the loss of ENaC function by reducing fluid movement into alveoli through paracellular pathways.
ROS levels are elevated in the PKC-␣ knockout lung. The lung is the only organ that is continuously exposed to high oxygen tension; therefore, alveolar ENaC is especially susceptible to ROS signaling in vivo (9 -11, 19, 38) . PKC-␣ can play an important role in regulating superoxide levels via activation of SOD (27) , and, indeed, we did find that ROS levels in the wild-type lungs were lower than in the knockout lung, whereas SOD activity was higher in wild-type than in knockout lungs. In the wild-type lung, PKC-␣ is active, stimulating SOD activity, which leads to ROS degradation, but, in the knockout lung, in the absence of PKC-␣, SOD activity is reduced and ROS levels are increased.
ENaC P o is decreased in the PKC-␣ knockout lung. In PKC-␣ knockout mice, ENaC P o is increased in renal principal cells of the collecting duct. However, in contrast to alveolar cells with multiple PKC isoforms, principal cells contain only There is a significant reduction between untreated wild-type and MKP-inhibited wildtype (n ϭ 4) and both knockout groups (indicated by an asterisk; n ϭ 5). There is no significant difference between MKP-inhibited wild-type, untreated knockout, and MKP-inhibited knockout (determined by 1-way ANOVA). C and D: there appears to be no effect of MKP inhibition on Po in either wild-type or knockout cells (paired t-test, n ϭ 4 and 5, respectively). . Active PKC-␦ is increased in the PKC-␣ knockout lung. Using Western blotting, we measured total PKC-␦ in whole lung homogenates from PKC-␣ knockout and wildtype mice. To become active, the inactive form of PKC-␦ must undergo modification. A: blot from alveolar type II cell lysates from wild-type and knockout animals (above). We determined that the amount of active PKC-␦, represented by the bottom band with a molecular weight around 50 kDa, is increased compared with the inactive form (*P Ͻ 0.01, n ϭ 6). B: we repeated the experiment in the presence of instilled PKC-␦ inhibitor to show that the inhibitor reduces the active form of PKC-␦ (n ϭ 6, difference in the ratio is not significant). We used Image J to quantify the blots. The program calculated the cumulative sum of the pixel values above the background for individual bands.
PKC-δ
PKC-␣ (3, 43) . Thus, in principle, cells knocking out PKC-␣ eliminates all PKC-mediated phosphorylation. In contrast, in alveolar epithelial cells, alternative isoforms can promote PKC phosphorylation. In particular, one isoform, PKC-␦, is activated by ROS (6, 38) . The mechanism by which P o is increased likely involves PIP 2 interaction with the channel. That ENaC gating depends on PIP 2 has been well known for a long time (25, 35-37, 44, 54 ENaC apical membrane density is decreased in the PKC-␣ knockout lung. In addition to a decrease in P o , we also observed an unexpected decrease in ENaC channel density at the apical membrane of the alveoli in the knockout lung. One known mechanism for reducing ENaC membrane density is via phosphorylation by active ERK1/2, which promotes ENaC interaction with the ubiquitin ligase Nedd4 -2. In turn, ubiquitination by Nedd4 -2 promotes ENaC internalization, therefore reducing the apical channel density at the membrane (4, 46, 52, 56) . ROS-activated PKC-␦ can phosphorylate and activate ERK1/2 (16 -18) . Also, ROS inhibits MKP, which leads to decreased ERK1/2 dephosphorylation (2, 42, 47) . The combination of There was a significant increase in the Po of ENaC in the PKC-␣ knockout mice after the addition of the PKC-␦ inhibitor (*P ϭ 0.009, n ϭ 16), whereas there was no significant change in the wild-type mice (C). Also, there was a significant increase in the channel density of ENaC at the membrane in the knockout mice (*P ϭ 0.003, n ϭ 10), after the addition of the PKC-␦ inhibitor, but there was no significant change seen in the wild-type animals (D). ENaC activity recorded from paired, cell-attached patches on isolated alveolar type II cells from wild-type mice, before and after addition of a general PKC inhibitor, GF109203X (500 nM). The inhibitor produced a large increase in every cell (*P Ͻ 0.001 by paired t-test, n ϭ 9). B: ENaC activity recorded from alveolar type II cells: untreated cells and treated with 100 nM phorbol myristoyl acetate (PMA) for 2 h before forming patches. ENaC activity was significantly inhibited in PMA-treated cells (*P Ͻ 0.001, n ϭ 20 for both treated and untreated).
PKC-␦ activation and MKP inhibition leads to elevated ERK phosphorylation and ERK1/2-dependent ENaC internalization.
Superoxide levels and ROS, in general, play a key role in regulating alveolar ENaC and the maintenance of normal lung function (11, 11, 24) . Previous literature has consistently reported that ROS has a stimulatory effect on ENaC activity (2, 9 -11, 19, 24, 38, 47, 51) . We were surprised to find that, in certain circumstances, elevated ROS can cause a decrease in ENaC activity, as seen in the PKC-␣ knockout lung. It seems that there are different roles for ROS in the regulation of ENaC, both inhibitory and stimulatory. We hypothesize that one unique characteristic of ROS signaling in the lung, which could lead to opposing regulatory effects on ENaC, is whether the ROS originated intracellularly or extracellularly. The absence of PKC-␣ in the lung affects intracellular ROS, whereas most of the previous literature, in both the kidney and the lung, in vivo and ex vivo, was concerned with the effect of extracellular ROS on ENaC activity. We will be interested to investigate in the future the discrete effects of extracellular and intracellular ROS on the regulation of alveolar ENaC. Figure 12 shows a schematic diagram of PKC signaling in the wild-type and knockout lung. Figure 12A shows the wildtype lung. PKC-␣ is active, stimulating SOD, which breaks down ROS. In the absence of ROS, PKC-␦ is inactive and does not phosphorylate MARCKS protein, which allows MARCKS to sequester PIP 2 near ENaC in the membrane, increasing ENaC P o . In addition, ERK1/2 is not phosphorylated by PKC-␦, so that ENaC density at the membrane is increased because of decreased internalization. In addition, without high levels of superoxide in the lung, MKP is active, which dephosphorylates ERK1/2, leading to reduced apical expression of ENaC. Figure 12B shows that, in the knockout lung, in the absence of PKC-␣, SOD is less active, leading to elevated ROS. ROS activates PKC-␦ and inhibits MKP. The combination leads to increased ERK1/2 phosphorylation via PKC-␦ and decreased dephosphorylation via MKP, which together activate ERK. ERK in turn phosphorylates ENaC, which promotes interaction with Nedd4 -2, causing the ubiquitination and subsequent internalization of ENaC. ROS activation of PKC-␦ promotes phosphorylation of MARCKS protein, which, when phosphorylated, leaves the membrane and does not sequester PIP 2 in proximity to ENaC. Without this interaction with PIP 2 , ENaC P o is decreased.
Our findings may also shed light on our understanding of AFC under basal vs. stimulated conditions. Although our experiments were conducted under basal conditions, the increase in ROS seen in the knockout animals partially mimics stimulated conditions in the alveoli. It has been previously reported that, under stimulated conditions, such as during infection by virus or treatment with LPS, a PKC inhibitor reversed downregulation of ENaC activity (20, 24, 31a) . Lazrak, et al. (31a) also demonstrated that the mechanism of decreased ENaC activity was due to increased ROS levels. Similarly, LPS is known to increase ROS levels and caused a similar decrease in ENaC activity (20) . Figure 12 illustrates this idea. Under basal conditions in WT mice, only low levels of PKC-␣ are active, and no other PKC isoform is active. Application of phorbol ester initially activates PKC-␣, which Fig. 12 . Schematic diagram of alveolar PKC signaling in wild-type and PKC-␣ knockout mice. A: wild-type lung. PKC-␣ is active, stimulating SOD, which breaks down ROS. In the absence of ROS, PKC-␦ is inactive and does not phosphorylate MARCKS protein, which allows MARCKS to sequester phosphatidylinositol phosphate (PIP2) near ENaC in the membrane, increasing ENaC Po. In addition, ERK1/2 is not phosphorylated by PKC-␦, so that ENaC density at the membrane is increased attributable to decreased internalization. In addition, without high levels of superoxide in the lung, MKP is active, which dephosphorylates ERK1/2, leading to reduced apical expression of ENaC. B: in the knockout lung, in the absence of PKC-␣, SOD is less active, leading to elevated ROS. ROS activates PKC-␦ and inhibits MKP. The combination leads to increased ERK1/2 phosphorylation via PKC-␦ and decreased dephosphorylation via MKP, which together activate ERK. ERK in turn phosphorylates ENaC, which promotes interaction with Nedd4 -2, causing the ubiquitination and subsequent internalization of ENaC. ROS activation of PKC-␦ promotes phosphorylation of MARCKS protein, which, when phosphorylated, leaves the membrane and does not sequester PIP2 in proximity to ENaC. Without this interaction with PIP2, ENaC Po is decreased.
reduces ENaC P o . This effect can be blocked with a PKC-␣ inhibitor (GÖ6976). Continued exposure to phorbol ester increases ROS, stimulates PKC-␦, and downregulates PKC-␣. Downregulation of PKC-␣ leads to downregulation of ENaC translation (48) . In the knockout mice, absence of PKC-␣ promotes an increase in ROS. The increased ROS in the alveoli of PKC-␣ knockout animals activates PKC-␦, causing a decrease in ENaC activity. We hypothesize that there is a similar situation present in stimulated lungs; increased levels of ROS cause increased activation of PKC-␦ and decreased ENaC activity in stimulated lungs, whereas PKC-␣ is active more under basal conditions. The results of the PKC-␦ inhibitor (Fig.  10) are consistent with this model. The effects of a generic PKC inhibitor and of phorbol ester on wild-type cells (Fig. 11 ) are also consistent with this model.
Our work has investigated the role of PKC phosphorylation in regulation of alveolar ENaC. Although ENaC regulation by PKC has been thoroughly examined in the kidney (3, 4, 32, 42, 48) , there has been only limited literature on the effect of PKC on ENaC in the lung. Based on the results of global PKC activation with phorbol ester or global inhibition with GF109203X, we hypothesize that a PKC-␣ and -␦ double knockout would cause ENaC activity to increase, as observed in renal cells. 
